PERSPECTA

News from every angle

Back to headlines

New Zealand approves MDMA for PTSD treatment following Australia's lead

New Zealand's pharmaceutical regulatory authority has approved the use of MDMA for treating severe post-traumatic stress disorder, marking a significant shift in mental health policy aligned with Australian regulations.

PostShare